Effect of Cigarette Smoking on High-Density Lipoprotein Cholesterol Levels: A Biochemical Study

Authors

  • Ranjana Srivastva 1M.Sc Student, department of Biochemistry, Santosh Medical College & Hospital, SDU, Ghaziabad, UP Author
  • Dr Juhi Aggarwal 2 Prof & Head, department of Biochemistry, Santosh Medical College & Hospital, SDU, Ghaziabad, UP Author
  • Mohini Arora Senior Tutor, department of Biochemistry, Santosh Medical College & Hospital, SDU, Ghaziabad, UP Author

Keywords:

Biochemistry

Abstract

Introduction

Cigarette smoking is a major modifiable risk factor for several chronic diseases, including atherosclerosis and cardiovascular disease. In addition to its direct toxic effects, cigarette smoking can adversely influence lipid metabolism and alter the concentration and function of circulating lipoproteins. High-density lipoprotein cholesterol (HDL-C) plays an important cardioprotective role through reverse cholesterol transport and other anti-atherogenic mechanisms. Previous studies have generally reported lower HDL-C concentrations among smokers; however, the influence of different intensities of smoking on HDL-C levels requires further evaluation.

Objective

The present study aimed to assess the effect of cigarette smoking on serum HDL-C levels in male smokers and to compare HDL-C concentrations among mild, moderate, and heavy smokers with those of healthy non-smokers.

Methods

This cross-sectional study was conducted over 12 months in the Department of Biochemistry in association with the Department of Respiratory Medicine at Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh. A total of 80 healthy male subjects aged 30–40 years were included. Twenty healthy non-smokers served as controls, while 60 smokers were categorized into mild, moderate, and heavy smoking groups, with 20 subjects in each group, according to smoking intensity expressed in pack-years. Subjects with alcohol consumption, previous smoking history, diabetes mellitus, hypertension, renal disease, chronic hepatic dysfunction, endocrine disorders, obesity, a family history of coronary heart disease, or the use of lipid-lowering drugs were excluded. Serum HDL-C was estimated following precipitation of LDL, VLDL, and chylomicrons, followed by enzymatic estimation of cholesterol in the supernatant.

Results

A progressive decline in serum HDL-C levels was observed with increasing smoking intensity. The mean ± SD HDL-C levels were 48.94 ± 3.92 mg/dL in controls, 38.31 ± 3.16 mg/dL in mild smokers, 32.10 ± 2.15 mg/dL in moderate smokers, and 30.71 ± 2.48 mg/dL in heavy smokers. The corresponding 95% confidence intervals were 47.11–50.78, 36.83–39.79, 31.09–33.11, and 29.55–31.87 mg/dL, respectively. HDL-C levels were significantly lower among smokers compared with controls, with a progressive reduction observed with increasing smoking intensity

Discussion

The findings demonstrate an adverse association between cigarette smoking and serum HDL-C concentration. The progressive decline in HDL-C with increasing smoking intensity supports a possible dose-related effect of smoking on lipid metabolism. Smoking-induced alterations in enzymes and proteins involved in HDL metabolism, including lecithin cholesterol acyltransferase and cholesteryl ester transfer protein, may contribute to reduced HDL-C levels and impaired cardioprotection.

Conclusion

Cigarette smoking was associated with significantly lower serum HDL-C levels, and greater smoking intensity was accompanied by a further reduction in HDL-C. These findings emphasize the importance of smoking prevention and cessation as part of strategies to reduce adverse cardiovascular risk.

Views: 2Downloads: 0

References

1. Reddy KS. Cardiovascular disease in India. World Health Stat Q. 1993;46(2):101–107.

2. American Heart Association. Cigarette smoking and cardiovascular disease.

3. Gossett LK, Johnson HM, Piper ME, Fiore MC, Baker TB, et al. Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol. 2009;3:372–378.

4. Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation: the relationship between cardiovascular disease and lipoprotein metabolism. Atherosclerosis. 2008;201:225–235.

5. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298:784–788.

6. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J. 2011;161:145–151.

7. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2–14.

8. Fagerström K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 2002;62(Suppl 2):1–9.

9. Pyrgakis VN. Smoking and cardiovascular disease. Hellenic J Cardiol. 2009;50:234.

10. Wynder EL, Harris RE, Haley NJ. Population screening for plasma cholesterol: community-based results from Connecticut. Am Heart J. 1989;117:649–656.

11. Pagan K, Hou J, Goldenberg RL, Cliver SP, Tamura T. Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy. Clin Chim Acta. 2001;306:103–109.

12. McCarty MF. Increased homocysteine associated with smoking, chronic inflammation and aging may reflect acute phase induction of pyridoxal phosphatase activity. Med Hypotheses. 2000;55:289–293.

13. GBD Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015. Lancet. 2017;389:1885–1906.

14. Howard G, Evans GW, et al. Cigarette smoking and progression of atherosclerosis. JAMA. 1998;279:119–124.

15. National Center for Chronic Disease Prevention and Health Promotion. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA; 2014.

16. Mayhan WG, Patel KP. Effect of nicotine on endothelium-dependent arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol. 1997;272–H2342.

17. Brewer HB. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2004.

18. Freeman DJ, Murray GD, et al. Smoking and plasma lipoproteins in man: effect on levels of HDL-C and subfraction distribution. Eur J Clin Invest. 1993;23(10):630–640.

19. Souliman S, Simon D, Harman WH, et al. Glycated hemoglobin, fasting and 2-hour plasma glucose in current, ex- and never-smokers. Diabetologia. 2014;57(1):30–39.

20. Taniguchi A, Nakai Y, Shakali M, et al. Relationship of regional obesity to insulin resistance in obese men. Am J Physiol Endocrinol Metab. 2002;282–E663.

21. Lean MEF, Hankey CR. Relationship between cigarette smoking and BMI. Int J Obes. 2005;29(2):236–243.

22. Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197–1209.

23. Potter BK, Pederson LL, Chan SS. Does a relationship exist between body weight, concerns about weight and smoking among adolescents? Nicotine Tob Res. 2004;6(3):397–425.

24. Wild SH. ABC of obesity: risk factors for diabetes and coronary heart disease. BMJ. 2006;333:1009–1011.

Downloads

Published

2026-11-17

Issue

Section

Volume 1, Issue 4 (November 2026)

How to Cite

Effect of Cigarette Smoking on High-Density Lipoprotein Cholesterol Levels: A Biochemical Study (R. S. Srivastva, D. J. A. Aggarwal, & M. A. Arora, Trans.). (2026). Journal of Advanced Multidisciplinary Studies (JAMS), 1(IV), Page 661-668. https://jamsjournal.org/JAMS/article/view/968

Similar Articles

You may also start an advanced similarity search for this article.